全文获取类型
收费全文 | 132886篇 |
免费 | 12040篇 |
国内免费 | 4796篇 |
出版年
2023年 | 1068篇 |
2022年 | 1189篇 |
2021年 | 4351篇 |
2020年 | 3140篇 |
2019年 | 3868篇 |
2018年 | 4037篇 |
2017年 | 3064篇 |
2016年 | 4612篇 |
2015年 | 6921篇 |
2014年 | 7873篇 |
2013年 | 8986篇 |
2012年 | 10551篇 |
2011年 | 9893篇 |
2010年 | 6051篇 |
2009年 | 5400篇 |
2008年 | 6748篇 |
2007年 | 6366篇 |
2006年 | 5641篇 |
2005年 | 5145篇 |
2004年 | 4640篇 |
2003年 | 4258篇 |
2002年 | 3924篇 |
2001年 | 3786篇 |
2000年 | 3531篇 |
1999年 | 2966篇 |
1998年 | 1598篇 |
1997年 | 1473篇 |
1996年 | 1376篇 |
1995年 | 1332篇 |
1994年 | 1141篇 |
1993年 | 935篇 |
1992年 | 1633篇 |
1991年 | 1329篇 |
1990年 | 1145篇 |
1989年 | 925篇 |
1988年 | 808篇 |
1987年 | 709篇 |
1986年 | 567篇 |
1985年 | 620篇 |
1984年 | 511篇 |
1983年 | 436篇 |
1982年 | 464篇 |
1981年 | 372篇 |
1980年 | 317篇 |
1979年 | 279篇 |
1978年 | 274篇 |
1977年 | 259篇 |
1976年 | 236篇 |
1974年 | 248篇 |
1973年 | 257篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
Single Cell Transcriptome Amplification with MALBAC 总被引:1,自引:0,他引:1
3.
The activation of endothelial cells is essential to repair damage caused by atherosclerosis via endothelial cell proliferation and migration. Overexpression of VEGF (vascular endothelial growth factor) and the downstream gene, B-cell lymphoma-2 (BCL-2) could result in apoptosis-resistant endothelial cells, which are responsible for aggravated hyperplasia and instable plaques generation. Previous studies have shown that miRNA126 could regulate the expression of VEGF. Here, we verified the existence of a miRNA126 binding site in VEGF’s 3’UTR. Additionally, VEGF regulated BCL-2 expression via AP1 (Activator Protein 1) binding site in BCL-2’s promoter. Next, we established an apoptosis-resistant endothelial cell line and constructed a lentiviral vector to express miRNA126 under the control of the BCL-2 promoter to investigate whether conditional expression of miRNA126 could modulate VEGF and BCL-2 expression in apoptosis-resistant endothelial cells. This lentiviral system specifically expressed miRNA126 in cells with high BCL-2 levels, downregulated VEGF expression, inhibited MAPK pathway activation and downregulated BCL-2 expression via suppression of AP1, and as a whole, reduced apoptosis-resistant endothelial cells, while the effects of miRNA126 on normal endothelial cells were relatively small. Our results demonstrate that conditional miRNA126 overexpression under the control of the downstream BCL-2 promoter provides a flexible regulatory strategy for reducing the apoptosis-resistant endothelial cells without having a significant impact on normal endothelial cells. 相似文献
4.
5.
6.
7.
Katherine E. Price Giulia Orazi Kathryn L. Ruoff Wesley P. Hebert George A. O’Toole Paul Mastoridis 《PloS one》2015,10(10)
Cystic Fibrosis (CF) is a human genetic disease that results in the accumulation of thick, sticky mucus in the airways, which results in chronic, life-long bacterial biofilm infections that are difficult to clear with antibiotics. Pseudomonas aeruginosa lung infection is correlated with worsening lung disease and P. aeruginosa transitions to an antibiotic tolerant state during chronic infections. Tobramycin is an aminoglycoside currently used to combat lung infections in individuals with CF. While tobramycin is effective at eradicating P. aeruginosa in the airways of young patients, it is unable to completely clear the chronic P. aeruginosa infections in older patients. A recent report showed that co-addition of tobramycin and mannitol enhanced killing of P. aeruginosa grown in vitro as a biofilm on an abiotic surface. Here we employed a model system of bacterial biofilms formed on the surface of CF-derived airway cells to determine if mannitol would enhance the antibacterial activity of tobramycin against P. aeruginosa grown on a more clinically relevant surface. Using this model system, which allows the growth of robust biofilms with high-level antibiotic tolerance analogous to in vivo biofilms, we were unable to find evidence for enhanced antibacterial activity of tobramycin with the addition of mannitol, supporting the observation that this type of co-treatment failed to reduce the P. aeruginosa bacterial load in a clinical setting. 相似文献
8.
9.
10.
Feng-Ming Chen Chang-Zheng Liu Shaik A. Gaffar Alan L. Epstein 《Journal of chromatography. B, Analytical technologies in the biomedical and life sciences》1991,563(2)
Lym-1 and TNT-1 are two murine immunoglobulin G2a monoclonal antibodies (MAbs) which have been used for clinical trials in cancer patients. This paper describes methods for large-scale preparation of F(ab')2 fragments from 50 mg to 4 g of MAbs Lym-1 and TNT-1. Digestion of MAbs with pepsin was optimized and performed at pH 3.8, a pepsin/antibody ratio of 1:250, and 3–4 h of incubation at 37°C. The F(ab')2 fragments were purified by tandem column procedures using fast protein liquid chromatography. Quality control analyses of the products included protein purity, isoelectric point, immunoreactivity, and endotoxin level. The results revealed that the chromatographic procedures are practical, simple, and effective, and can be used to produce gram quantities of clinical-grade F(ab')2 fragments for the diagnosis of cancer in patients. 相似文献